Medical Nutrition International Industry
Recent meetings
No recorded meetings with EU commissioners.
Mission & Goals
MNI was founded by leading international companies specialized in medical nutrition. The mission of MNI is to bring together companies that provide products and services to optimize patient outcome through specialized nutritional solutions.
EU Legislative Interests
Regulation (EU) No 609/2013 and Commission delegated regulation (EU) 2016/127 Regulation 2018/1584 Regulation 2018/848
Communication Activities
MNI published its Manifesto in 2024 calling for integrating nutritional care as a core component of the patient care pathway https://www.medicalnutritionindustry.org/better-care-through-better-nutrition-mni-launches-its-call-for-integrating-nutritional-care-as-a-core-component-of-the-patient-care-pathway/ MNI published information related to Covid19 and malnutrition as well as information on malnutrition and cancer in 2020 and 2021 https://medicalnutritionindustry.com/medical-nutrition/medical-nutrition-dossier/ MNI has published in February 2018 the dossier entitled 'Better care through better nutrition: Value and effects of medical nutrition' https://www.medicalnutritionindustry.org/content/uploads/2023/11/2018_mni_dossier_final_web.pdf
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
ISDI: http://www.isdi.org
Organisation Members
Abbott Baxter B.Braun Fresenius-Kabi Nestlé Health Science Nutricia Specialized Nutrition
Connected Legislation
Correction: Delegated Regulation (EU) 2021/577 (Veterinary medicinal products)
Prohibition of certain antimicrobial products in animal imports
Amendment: Annex II to Regulation (EU) 2019/6
Supplementing Regulation (EU) 2019/6: Single lifetime identification document
Regulation on the volume of sales and on the use of antimicrobial medicinal products in animals
Veterinary medicinal products
Regulation on appropriate measures to ensure the effective and safe use of veterinary medicinal products authorised and prescribed for oral administration via routes other than medicated feed and administered by the animal keeper to food-producing animals
Amendment to Regulation (EU) 2019/6 on compliance with good laboratory practice for veterinary medicinal products set out in Annex II to that Regulation
Regulation on the criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans